![](/assets/default_company_panoramic_image-25937d8eab89e89a7dc30165ae221f7d4020dd13520c1d30da88bbbea34367f7.png)
![](https://gust-production.s3.amazonaws.com/uploads/startup/logo_image/630159/FEMSelect_20-_20color_20_tall_.jpg)
FEMSelect Ltd. (formerly POP Medical Solutions Ltd.)
FEMSelect (formerly POP Medical) developed EnPlace, a minimally invasive, mesh-free approach to prolapse repair. Standard of care is complex & invasive surgery.
- Stage $1M in TTM Revenue
- Industry Medical Devices and Equipment
- Location Tel Aviv Region, Israel
- Currency USD
- Founded December 2012
- Employees 5
- Incorporation Type C-corp
- Website femselect.com
Company Summary
FEMSelect developed EnPlace – a minimally invasive, mesh-free approach to prolapse repair that has FDA clearance and CE Mark. Women experience minimal pain & recover in days. Standard of care is complex and invasive surgery in a $10B global market. FEMSelect has begun selling the disposable device in Israel and in the US with its US partner, LiNA Medical USA, and is raising a Round B to expand US commercialization.
Team
Advisors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.